Print | Need Larger Text?

Incident Report

Subform I: General Information

1. Report Type.

New incident report

Incident Report Number: 2021-3024

2. Registrant Information.

Registrant Reference Number: FMC-55313

Registrant Name (Full Legal Name no abbreviations): FMC Corporation

Address: 2929 Walnut Street

City: Philadelphia

Prov / State: Pennsylvania

Country: USA

Postal Code: 19104

3. Select the appropriate subform(s) for the incident.

Scientific Study

4. Date registrant was first informed of the incident.

5. Location of incident.

6. Date incident was first observed.

Product Description

7. a) Provide the active ingredient and, if available, the registration number and product name (include all tank mixes). If the product is not registered provide a submission number.

PMRA Registration No. 28572      PMRA Submission No.       EPA Registration No.

Product Name: AIM Technical

• Active Ingredient(s)
  • CARFENTRAZONE-ETHYL
    • Guarantee/concentration 91.7 %

7. b) Type of formulation.

Application Information

8. Product was applied?

Unknown

9. Application Rate.

10. Site pesticide was applied to (select all that apply).

11. Provide any additional information regarding application (how it was applied, amount applied, the size of the area treated etc).

To be determined by Registrant

12. In your opinion, was the product used according to the label instructions?

Unknown

Subform VII: Scientific Study

1. Study Reference

Title Hydrolysis under Typical Conditions (pH, Temperature and Time) of Processing

Date 27-MAY-21

2. a) Is an extension needed to translate the document?

No

3. Type of incident identified in the study

Presence of a component or derivitive

4. Describe the incident identified in the study (e.g. study demonstrates an increased risk to non-Hodgkin's Lymphoma after exposure to pesticide X)

The objective of this study was to determine whether or not breakdown or reaction products could arise from Carfentrazone-ethyl residues in the raw commodities during processing. Two major transformation products (10 % applied radioactivity = AR) were detected and identified under the conditions of sterilisation for both labels: F8426-chloropropionicacid (MH5), and F8426-deschloro-hydroxy-propionic acid (IN-XNX51-000, MH6).

5. a) Was the study discontinued before completion?

No

5. b) Provide the reason for discontinuation

6. If the study is ongoing, what is the expected completion date?

For Registrant use only

7. Provide supplemental information here